The largest database of trusted experimental protocols
> Procedures > Laboratory Procedure > Radioimmunoassay

Radioimmunoassay

Radioimmunoassay is a highly sensitive analytical technique used to quantify and detect specific substances, such as hormones, drugs, or other biomolecules, in biological samples.
This method combines the specificity of antibody-antigen interactions with the sensitivity of radioactive isotope detection.
Radioimmunoassays involve the use of a radioactively labeled analyte that competes with the unlabeled analyte from the sample for binding to a limited amount of specific antibody.
The amount of radioactive analyte bound to the antibody is inversly proportional to the concentration of the unlabeled analyte in the sample, allowing for accurate quantification.
This powerful technique has numerous applications in clinical diagnostics, pharmacology, and biochemical research, enabling precise measurement of a wide range of target analytes with high sensitivity and specificity.
Leveraging the power of artificial intelligence, researchers can optimize their radioimmunoassay experiments by easily comparing protocols from literature, pre-prints, and patents to identify the best procedures and products for improved reproducibility and accuracy.

Most cited protocols related to «Radioimmunoassay»

Besides a clinical and laboratory evaluation, each subject underwent a liver ultrasonography, an anthropometric assessment and a 7-day diary of food intake (7DD) [1 (link)]. HBsAg and anti-HCV antibodies were assessed and subjects with anti-HCV antibodies underwent an HCV-RNA assessment to confirm HCV infection [1 (link),14 (link)]. ALT, aspartate transaminase (AST), GGT, glucose, triglycerides and cholesterol were measured by standard laboratory methods after 8-hr fasting. Insulin was measured by radio-immuno-assay (ADVIA Insulin Ready Pack 100, Bayer Diagnostics, Milan, Italy), with intra- and inter-assay coefficients of variation < 5%. FL was diagnosed by the same operator at ultrasonography [6 (link)]. Weight, stature, circumferences (waist and hip) and skinfolds (triceps, biceps, subscapular and suprailiac) were measured by two trained dietitians who had been standardized before and during the study according to standard procedures [15 ]. Body mass index (BMI) was calculated as weight (kg)/stature (m)2 and the sum of 4 skinfolds by summing triceps, biceps, subscapular and suprailiac skinfolds [16 (link),17 (link)]. The 7DD was administered to the subjects by two trained dietitians, who discussed it with the subject when she/he returned it one week later [18 (link)]. To avoid the confounding effect of seasonality on food intake, the 7DD diary was administered to a similar number of patients with and without SLD each month [19 ]. Mean daily ethanol intake was calculated as the mean value of ethanol intake as assessed by the 7DD [20 ]. The study protocol was approved and supervised by the Scientific Committee of the Fondo per lo Studio delle Malattie del Fegato (Trieste, Italy), and all subjects gave their written informed consent to participate.
Publication 2006
Aspartate Transaminase Biological Assay Body Height Cholesterol Dietitian Eating Ethanol Glucose Hepatitis B Surface Antigens Hepatitis C Hepatitis C Antibodies Index, Body Mass Insulin Liver Patients Radioimmunoassay Triglycerides Ultrasonography
All procedures followed the Institute of Laboratory Animal Research guidelines and were approved by the Animal Care and Use Committee of the National Institute of Mental Health. Transgenic mice expressing HSV-TK under the GFAP promoter were generated from a previously-generated plasmid28 (link) using standard techniques and bred on a mixed C57Bl/6:CD-1 background. Male v-WT and v-TK mice were treated with valganciclovir for 8 weeks (dexamethasone experiment), 10-19 weeks (endocrine), 12 weeks (behavior) or 4 weeks (histology; histology after 12 weeks in Supplementary Fig. 1), beginning at 8 weeks of age. Male C57Bl/6 mice were irradiated under pentobarbital anesthesia, as described previously29 (link), and tested 9 weeks later. For immunohistochemical analyses, mice were given BrdU 6 weeks (for PVN analysis) or 24 hours prior to sacrifice, brain sections were immunostained as previously described29 (link), and labeled cells were counted stereologically.
Serum corticosterone was measured by radioimmunoassay (MP Biomedicals) from submandibular blood samples obtained directly from the home cage condition or after exploration of a novel box, restraint, or isoflurane exposure. For the dexamethasone suppression test, dexamethasone (Sigma; 50 μg/kg in propylene glycol) or vehicle were injected 90 min prior to restraint, and blood was sampled immediately following 10 min restraint.
Behavioral tests were performed following 30 min of restraint or directly from the home cage. Different cohorts of mice were tested in the NSF test, elevated plus maze, forced swim test and sucrose preference test as previously described.12 (link), 18 (link), 21 , 30 (link) Statistical analyses were performed by t-test, log-rank test, or ANOVA with Fisher's LSD test for post hoc comparisons. Significance was set at P<0.05.
Publication 2011
Anesthesia Animals Animals, Laboratory Behavior Test BLOOD Brain Bromodeoxyuridine Cells Corticosterone Dexamethasone Elevated Plus Maze Test Glial Fibrillary Acidic Protein Isoflurane Males Mice, Inbred C57BL Mice, Laboratory Mice, Transgenic neuro-oncological ventral antigen 2, human Pentobarbital Propylene Glycol Radioimmunoassay Serum Sucrose System, Endocrine Valganciclovir
C57BL/6J male mice (2–5 months of age) were housed individually on a 12 hr/12 hr light/dark schedule with lights on at 7 A.M. (ZT0) and handled for 6 days. Mice were sleep-deprived (SD) in their home cages for 5 hours by gentle handling beginning at ZT5 or left undisturbed (non-sleep-deprived mice, NSD). For contextual fear conditioning experiments, animals were placed in a novel chamber for 3 minutes, and received a 2-second, 1.5 mA footshock after 2.5 minutes. Half of the mice were deprived of sleep for 5 hours post-training. Mice received intra-peritoneal injections of rolipram (ROL; 1 mg/kg) or vehicle (2% DMSO in 0.9% saline) immediately and 2.5 hours post-training. Testing of contextual memory was performed 24 hours after training in the trained context and 48 hours after training in a novel chamber.
Electrophysiological recordings were carried out as previously reported28 (link). 1-train LTP was induced by a single 100 Hz, 1-second duration train of stimuli. 4-train LTP consisted of 4 trains applied with a 5-minute inter-train interval; for massed 4-train LTP a 5-second inter-train interval was used. Theta-burst stimulation (TBS) consisted of 40-ms duration, 100 Hz bursts delivered at 5 Hz for 3 seconds (15 bursts of 4 pulses per burst, for a total of 60 pulses). Chemical LTP was induced by treatment of slices for 15 minutes with 5µM forskolin (FSK) in 0.1% ethanol, or a combination of 50µM forskolin and 30µM 3-isobutyl-1-methylxanthine (IBMX, in water). Rolipram (0.1µM in 0.1% DMSO) was applied for 60 minutes, beginning 30 minutes before tetanization.
cAMP assays on CA1 regions of hippocampal slices 10 minutes after treatment for 15 minutes with forskolin (50µM), forskolin + IBMX (30µM), or vehicle (0.1% EtOH) were performed by radioimmunoassay according to kit instructions. cAMP-specific PDE activity assays29 (link) and Western blots for PDE4A530 (link) were performed as previously described.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
Publication 2009
1-Methyl-3-isobutylxanthine Aftercare Animals Biological Assay CA1 Field of Hippocampus Colforsin Ethanol Fear Injections, Intraperitoneal Light Males Memory methylxanthine Mice, House Mice, Inbred C57BL Neoplasm Metastasis Normal Saline Pulses Radioimmunoassay Rolipram Sleep Sulfoxide, Dimethyl Western Blot

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2009
Blood Glucose Diabetes Mellitus Diagnosis Enzyme-Linked Immunosorbent Assay Fluorides Glucose Homo sapiens Insulin Insulin Sensitivity Natural Springs Oral Glucose Tolerance Test Oxidase, Glucose Pharmaceutical Preparations Physicians Physiology, Cell Plasma Radioimmunoassay Serum Veins
Blood samples for serum 25(OH)D testing collected during the examination were centrifuged, divided into aliquots, and frozen to −70°C on site and then shipped on dry ice to central laboratories, where they were stored at −70°C until analysis. Serum 25 (OH)D levels were measured by a radioimmunoassay kit after extraction with acetonitrile (DiaSorin, Stillwater, Minnesota) by the National Center for Environmental Health (Atlanta, Georgia). Because risk factors for vitamin D insufficiency have been extensively explored in previous NHANES analyses,30 (link) we focused the current analysis on self-reported age, sex, and race/ethnicity collected during the household interview to evaluate changes in previously documented demographic disparities in vitamin D insufficiency.31 (link),32 Because the month of data collection was not publicly reported in NHANES 2001–2004 (owing to protection of confidentiality), we did not record or control for season.
Publication 2009
acetonitrile Dry Ice Ergocalciferol Ethnicity Freezing Households Radioimmunoassay Serum

Most recents protocols related to «Radioimmunoassay»

Plasma insulin was measured using an in-house radioimmunoassay, using an in-house-generated guinea pig anti-human insulin antibody and 125I-labelled human insulin tracer. 125I-labelled human insulin tracer was generated using 125I (PerkinElmer Nederland) and human insulin (Novo Biolabs cat. no. 471). In this assay, bound–free separation is performed by second antibody/polyethylene glycol precipitation of antibody-bound insulin. The assay is calibrated on World Health Organization international standard 83/500. The cross-reactivity in this method is approximately 60% for insulin aspart and 50% for insulin lispro. The cross-reactivity for insulin degludec is not well known. Catecholamines were analysed by an LC-MS/MS method developed and validated in-house after derivatisation with propionic anhydride and subsequent solid-phase extraction [26 (link)]. Plasma cortisol was determined using a routine analysis method with an electrochemiluminescent immunoassay on a Cobas E801 random access analyser (Roche Diagnostics, Mannheim, Germany) [27 (link)].
Publication 2023
Biological Assay Catecholamines Cavia Cross Reactions Diagnosis Homo sapiens Hydrocortisone Immunoassay Insulin Insulin Antibodies Insulin Aspart insulin degludec Insulin Lispro Plasma Polyethylene Glycols propionic anhydride Radioimmunoassay Solid Phase Extraction Tandem Mass Spectrometry

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Biological Assay Biopharmaceuticals BLOOD Catalase Cholesterol Cholesterol, beta-Lipoprotein Diagnosis Enzyme-Linked Immunosorbent Assay Estradiol Follicle-stimulating hormone High Density Lipoprotein Cholesterol Insulin L-alpha-glycerol-phosphate oxidase Low-Density Lipoproteins Luteinizing hormone Mice, House Radioimmunoassay Serum Surface-Active Agents Testosterone Triglycerides
Blood was collected by qualified research assistants using a standardized protocol (Supplementary Data). Blood for chemistry and hematology measurements was analyzed by the UMCG. Plasma glucose concentration was measured on an YSI 2300 Stat glucose/lactate analyzer (YSI, Inc., Yellow Springs, OH). Serum insulin concentration was measured using radioimmunoassay (Diagnostic Laboratories, Los Angeles, CA) (Cree et al, 2008 (link)). Total GLP-1, GLP-2, and ghrelin were analyzed at DSM Nutritional Products, Switzerland, by using commercially available ELISA kits (Millipore Corp).
Publication 2023
BLOOD Blood Chemical Analysis Diagnosis Enzyme-Linked Immunosorbent Assay GHRL protein, human Glucagon-Like Peptide 1 Glucose Insulin Lactates Natural Springs Plasma Radioimmunoassay Serum

Perioperative indexes of the two groups (observation of intraoperative blood loss, operation time, and number of lymph node dissection). (2) Determination of tumor markers: after treatment, 5 ml of fasting elbow vein blood was drawn from the patient, the supernatant was centrifuged, and CYFRA21-1, CA125, as well as VGEF levels were measured by radioimmunoassay. (3) Immune function: after centrifugation of the above patients' serum, CD4+, CD3+, and CD4+/CD8+ were measured via flow cytometry (American BD company, FACS Vantage type). (4) Adverse reaction determination: record the occurrence of complications of the two groups of patients during treatment

Publication 2023
BLOOD CA-125 Antigen Centrifugation Elbow Flow Cytometry Immune System Processes Lymph Node Excision Patients Radioimmunoassay Serum Surgical Blood Losses Tumor Markers Veins
Venous blood samples were collected the morning after PSG following at least 8 h of fasting. Biochemical parameters of renal function and lipid profile, as well as glucose and C‐reactive protein (CRP) serum levels were measured using an automated analyser. Serum biochemical parameters were determined using a commercial radioimmunoassay kit and the manufacturer's specifications the day of blood sampling (DiaSorin, Stillwater, MN, USA).
Publication 2023
C Reactive Protein Glucose Kidney Lipids Radioimmunoassay Serum Veins

Top products related to «Radioimmunoassay»

Sourced in United States, United Kingdom, Germany
Radioimmunoassay is a sensitive analytical technique used to measure the concentration of specific substances, such as hormones, in a sample. It combines the use of radioactive isotopes and the highly specific interaction between an antigen and its corresponding antibody to quantify the target analyte. The core function of radioimmunoassay is to provide accurate and precise measurements of trace amounts of analytes in complex matrices.
Sourced in United States, Sao Tome and Principe, Germany
Radioimmunoassay is a sensitive analytical technique used to measure the concentration of specific substances, such as hormones, proteins, or drugs, in a sample. It employs the use of radioactive isotopes and antigen-antibody interactions to quantify the target analyte.
Sourced in United States, United Kingdom
Radioimmunoassay (RIA) kits are laboratory equipment used to measure the concentration of specific analytes, such as hormones, proteins, or drugs, in a sample. The kits utilize the principles of radioimmunoassay, a sensitive and quantitative analytical technique that relies on the competitive binding of a radioactively labeled analyte and an unlabeled analyte to a limited number of specific antibody binding sites.
Sourced in United States, Italy
The Radioimmunoassay (RIA) kit is a laboratory equipment used for the quantitative determination of analytes in biological samples. It employs the principles of radioimmunoassay technology to measure the concentration of target molecules. The kit provides the necessary reagents and materials to perform the RIA analysis.
Sourced in United States
The Radioimmunoassay (RIA) kit is a laboratory equipment used for the quantitative determination of small amounts of substances, such as hormones, drugs, or other analytes, in biological samples. It utilizes the principle of competitive binding between the analyte in the sample and a radiolabeled form of the analyte to a limited number of specific antibody binding sites.
Sourced in Germany, United States, United Kingdom, Italy, Spain, Japan
The Immulite 2000 is an automated immunoassay analyzer designed for in vitro diagnostic testing. It is capable of performing a variety of immunoassay tests, including those for hormones, proteins, and other analytes. The system utilizes chemiluminescent technology for detection and provides automated sample handling, reagent management, and result reporting.
Sourced in United States, Sao Tome and Principe
The Radioimmunoassay (RIA) kit is a laboratory equipment designed for the quantitative determination of specific analytes in biological samples. It utilizes the principles of radioimmunoassay, a highly sensitive and accurate technique for the measurement of low concentrations of various substances, such as hormones, drugs, and other biomolecules.
Sourced in United States, Germany
Coat-A-Count is a laboratory equipment product manufactured by Siemens. It is a fully automated radioimmunoassay (RIA) system used for the quantitative determination of various analytes in biological samples. The core function of Coat-A-Count is to perform sensitive and precise immunoassay measurements through a standardized and streamlined process.

More about "Radioimmunoassay"

Radioimmunoassay (RIA) is a highly sensitive analytical technique used to quantify and detect specific substances, such as hormones, drugs, or other biomolecules, in biological samples.
This method combines the specificity of antibody-antigen interactions with the sensitivity of radioactive isotope detection.
RIAs involve the use of a radioactively labeled analyte that competes with the unlabeled analyte from the sample for binding to a limited amount of specific antibody.
The amount of radioactive analyte bound to the antibody is inversly proportional to the concentration of the unlabeled analyte in the sample, allowing for accurate quantification.
This powerful technique has numerous applications in clinical diagnostics, pharmacology, and biochemical research, enabling precise measurement of a wide range of target analytes with high sensitivity and specificity.
Radioimmunoassay kits and Immulite 2000 are examples of commercially available RIA products that leverage this technology.
Researchers can optimize their RIA experiments by easily comparing protocols from literature, pre-prints, and patents to identify the best procedures and products for improved reproducibility and accuracy.
By leveraging the power of artificial intelligence, tools like PubCompare.ai can take the guesswork out of RIA research, enabling scientists to make more informed decisions and drive better outcomes.